COVID-19 plasma treatment, Takeda alliance development timeline – Business Insider

If all goes well, the plasma-based therapy could be approved before year’s end as one of the first COVID-19 drugs to reach market.

  1. 10 drugmakers are working together to develop a treatment based on the blood of COVID-19 survivors, and they plan to start testing in humans next month